Navigation Links
ClinStar to Be Featured on Business Day TV With Terry Bradshaw

SAN FRANCISCO, Dec. 8, 2011 /PRNewswire/ -- ClinStar, LLC, an established CRO providing clinical research services in the emerging markets of Russia and Eastern Europe to the biopharmaceutical industry, announced today that it is being featured in a Medical Minutes series by Business Day TV hosted by Terry Bradshaw. 

According to the episode, it takes approximately 10 to 15 years and over one billion dollars to launch a new drug, and even then, only one in five products generate enough revenue to break-even. To speed up the process, biopharmaceutical companies utilize the services of Contract Research Organizations (CROs) to conduct the clinical research phase in patients. However, with qualified and interested patients becoming more difficult to find in the West, the industry is turning to CROs like ClinStar that geographically specialize in emerging markets. 

"More and more clinical research is being conducted outside the traditional markets of North America and Western Europe," says David Passov, President and CEO of ClinStar. "This is not necessarily driven only by somewhat lower cost but rather by the ability to significantly speed up drug development by accessing a global population of 7 billion people."

Specializing in the emerging markets of Russia, Ukraine, Belarus and the Baltic States, ClinStar leverages the region's combined population of over 200 million and the support of physicians and government regulatory bodies to enjoy recruitment rates up to 20 times faster than in the West.

"By conducting clinical trials in emerging markets, biopharmaceutical organizations are able to reduce the time to develop a drug," says Mr. Passov. "This not only translates into cost savings for the biopharmaceutical industry but results in faster access to better medicines for us all." 

View the full-length version of ClinStar featured on Business Day TV

Heather Newbold
919-354-3573 ext. 276

About ClinStar, LLC
ClinStar is one of the most prominent CROs in the emerging markets of Eastern Europe and the Baltics with more than 10 years of expertise in Phase I-IV clinical studies in multiple therapeutic areas. Headquartered in San Francisco, California, ClinStar manages studies from its offices in Russia, Ukraine and Belarus, with total staff of over 260 people. Its portfolio contains over 130 clinical trials conducted for US and European pharmaceutical and biotechnology companies. More information is available at

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ClinStar to Present on Clinical Trial Recruitment in the Emerging Regions of Russia and Eastern Europe
2. ClinStar to Present on Russias Performance as an Emerging Market in Global Clinical Trials
3. ClinStar to Present on Conducting Clinical Trials in Russia
4. ClinStar, LLC Establishes New Office on the US East Coast
5. Diplomat Specialty Pharmacy Recipient of MichBio Good to Great Award; Also Featured in Pure Michigan Video Exemplifying Flints Resurgence and Michigans Future
6. PLC Systems RenalGuard® to be Featured in Chronic Kidney Disease and Contrast Nephropathy Session at TCT 2011
7. Groundbreaking Approach to Predicting Cancer Patients Response to Treatment Featured in Science Magazine
8. Intellect Neurosciences CEO to be Featured on Wall Street Reporter
9. Additional Analysis from Two-Year Sequel Study of QNEXA Featured at The 2011 Annual Scientific Meeting of The Obesity Society
10. Medical Care Technologies Inc. to be Featured Guest on Business Radio Show Your Monies Worth
11. Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
(Date:11/25/2015)... November 25, 2015 Kitov Pharma ... (TASE: KTOV), a biopharmaceutical company focused on the development ... clinical conditions, today announced the closing of its previously ... ( ADSs ), each representing 20 ordinary shares of ... ADSs. The ADSs and warrants were issued in a ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... the way that they are handling security in light of the recent terrorist attacks ... in an attempt to stop an attack from reaching U.S. soil. Especially around special ...
(Date:11/27/2015)... ... November 27, 2015 , ... An ... way to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC ... and dispense prescription medications. In doing so, it could help to prevent potential ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with ... the 2016 Building Better Radiology Marketing Programs meeting will showcase some ... March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
Breaking Medicine News(10 mins):